Moreover, genetic activation of mTOR, which is in part downstream of IGF-1 signaling, is reported to trigger Trem2 activity and enhanced amyloid clearance40, whereas Trem2 loss-of-function mutations, such as R47H, are commonly associated with AD. This evidence concerns the gene IGF1 and Alzheimer disease.